Tauopathies feature progressive accumulation of tau amyloids. Pathology may begin when 30 these amplify from a protein template, or seed, whose structure is unknown. We have purified 31 and characterized distinct forms of tau monomer-inert (Mi) and seed-competent (Ms). 32
material was immediately collected and used in seeding assay along with the non-filtered 140 samples of the same fraction at a final concentration of 100nM, or analyzed by limited 141 proteolysis. Protein concentration was determined before and after filtration by determining 142 absorption at 205nm. 143 144 CD spectroscopy 145 Circular dichroism (CD) measurements were performed at 25°C on a Jasco J-815 146 spectropolarimeter using a 0.1cm optical path length. 200μL of 2μM Ms or Mi monomer was 147 dialyzed onto 10 mM NaP and the spectra were measured at 0.10 nm intervals, with a band 148 width of 1.0nm, and scan speed of 10nm/min. The spectrum represents the average of 4 149 scans in the range of 195 to 250nm. 150 151
Enzyme-linked immunosorbent assay 152 A total tau "sandwich" ELISA was performed similarly to that described previously 16 . 153 Antibodies were kindly provided by Dr. Peter Davies (Albert Einstein College of Medicine were incubated at room temperature for 20min before adding to cells. Cells were incubated 180 with transduction complexes for 24h. 181 182
FRET flow cytometry 183
Cells were harvested with 0.05% trypsin and fixed in 2% paraformaldehyde (Electron 184 Microscopy Services) for 10min, then resuspended in flow cytometry buffer. The MACSQuant 185 VYB (Miltenyi) was used to perform FRET flow cytometry. To measure CFP and FRET, cells 186
were excited with a 405nm laser, and fluorescence was captured with 405/50nm and 187 525/50nm filters, respectively. To measure YFP, cells were excited with a 488nm laser and 188 fluorescence was captured with a 525/50nm filter. To quantify FRET, we used a gating 189 strategy similar to that previously described 9 . The integrated FRET density (IFD), defined as 190 the percentage of FRET-positive cells multiplied by the median fluorescence intensity of 191 FRET-positive cells, was used for all analyses. For each experiment, ~20,000 cells were 192 analyzed in triplicate. Analysis was performed using FlowJo v10 software (Treestar). 193 194
Tau seeding in vitro 195 Recombinant full length (0N4R) tau monomer was purified as previously described 19 at 196 1mg/mL in BRB80 buffer (80mM PIPES, 1mM MgCl2, 1mM EGTA, pH 6.8 with 0.3M NaCl) 197 and boiled at 100°C for 5min with 25mM β-mercaptoethanol. The tau protein solution was 198 then rapidly diluted 1:5 and cooled to 20°C in PBS, pH 7.4, to a final concentration of 199 0.2mg/mL of tau and 5mM β-mercaptoethanol. This solution was supplemented with 200
Thioflavin T (ThT) to a final concentration of 20µM and filtered through a sterile 0.2µm filter. 201
Reaction sizes of 195µL were aliquoted from the prepared protein stock and thoroughly 202 mixed with 5µL of each sample at 100nM monomer equivalent, or 5µL of buffer control. For 203 each sample, three different technical replicates were prepared. An opaque 96-well plate was 204 prepared with a 3mm glass bead added to each well to increase agitation. The recombinant 205 tau solution was added to the plate in 200µl reaction volumes. The plate was sealed with 206 sealing tape to prevent evaporation and incubated in the plate reader (SpectraMax M2) at 207 37°C. ThT fluorescence was monitored over time with excitation and emission filters set to 208 444nm and 485nm, respectively. Fluorescence readings were taken every 5min, with 209 agitation for 5sec before each reading. 210 211
Tau extraction from brain and characterization by SEC 212 0.5g frontal lobe sections from AD patients at late Braak stage (VI) and age-matched controls 213 lacking evident tau pathology were gently homogenized at 4°C in 5mL of TBS buffer 214 containing protease inhibitor cocktails (Roche) using a dounce homogenizer. Samples were 215 centrifuged at 21,000 x g for 15 min at 4°C to remove cellular debris. Supernatant was 216 partitioned into aliquots, snap frozen and stored at -80°C. Immunopurification was performed 217 with HJ8.5 anti-tau antibody 20 at a ratio of 1:50 (1µg mAb per 50µg of total protein), 218
incubating overnight at 4°C while rotating. To each 1mL of mAb/brain homogenate we added 219
200µL of a 50% slurry protein G-agarose beads (Santa-Cruz). We washed the bead with TBS 220 buffer before overnight incubation at 4°C. We then centrifuged the complexes at 1000 x g for 221 3min and discarded the supernatant. Beads were washed with Ag/Ab Binding Buffer, pH 8.0 222 (Thermo Scientific) three times. Tau bound to the beads was eluted in 100 µL low pH elution 223 buffer (Thermo Scientific), incubated at room temperature for 7min, followed by neutralization 224 with 10µL Tris-base pH 8.5. This elution step was repeated once more with 50 µL elution 225 buffer and 5µL Tris-base pH 8.5 for a total of 165µL. Samples were then centrifuged at 226 10,000 x g for 10min, and the supernatant loaded onto a Superdex 200 Increase 10/300 GL 227 column (GE Healthcare). SEC fractions were frozen at -80°C after evaluation of protein 228 content by Micro BCA assay (Thermo Scientific). 229 230
To compare different extraction methods, fresh frozen frontal lobe section from an AD patient 231 brain was suspended in TBS buffer containing protease inhibitor cocktails (Roche) at 10% 232 w/vol in 4 portions. Samples were homogenized using 3 different devices: a dounce 233 homogenizer, probe sonicator (Omni International), and tissue homogenizer (Power Gen 125, 234
Fischer Scientific). We also included one more condition of homogenizing with tissue 235 homogenizer followed by probe sonication for 10min. Samples were centrifuged at 21,000 x g 236 for 15min at 4°C to remove cellular debris. Supernatant was partitioned into aliquots followed 237 by immunopurification. 238 239
To control for release of tau Ms from fibrils in AD brain, a tau KO Mouse brain was divided  240  into two halves, followed by spiking one half with recombinant fibrils and the other with fibril-241  derived Ms, both at final concentration of 10µM monomer equivalent. Each was dounce  242 homogenized, centrifuged, immunoprecipitated with HJ8.5 anti-tau antibody, and fractionated 243
by SEC with identical techniques as used for human brain processing. SEC fractions were 244 then used in seeding experiments. 245 246 247
Analysis of heat denaturation data 248 We analyzed the IFD from measurements of temperature dependent seeding using global fits 249 to a proposed unimolecular heat denaturation reaction. This analysis rests on the Arrhenius 250 equation 21 : 251
where kU is the unfolding rate constant, E is the activation energy, R is the gas constant, T is 253 the temperature, and A is the pre-exponential factor. For the unimodal model, the data were 254 fit globally to: 255 IFD( ) = 100 &2/4 . 256 257
Here, t is the heat denaturation time and t = 1/kU is the unfolding time. A second, multimodal 258 model was deployed to account for discrepancies in the early time points which appeared to 259
suggest the presence of a lag phase in denaturation. was performed using the following criteria: xQuest score > 16, mass error between -4 and 327 +7ppm, %TIC > 10, and a minimum peptide length of six aa. In addition, at least four 328 assigned fragment ions (or at least three contiguous fragments) were required on each of the 329 two peptides in a crosslink. False discovery rates (FDR) for the identified crosslinks were 330 estimated using xprophet 24 . For the recombinant samples, Mi and Ms, the FDR ranged from 331 6-10%. Post-search manual validation of the brain-derived samples was performed using the 332 following criteria: xQuest score > 7, mass error between -5 and +7ppm, %TIC > 10, and a 333 minimum peptide length of six aa. In addition, at least four assigned fragment ions (or at least 334 three contiguous fragments) were required on each of the two peptides in a crosslink. The 335
FDRs for the brain samples were much higher and ranged between 20-25%. For triplicate 336 datasets corresponding to the Mi and Ms boiling time course we computed consensus 337 crosslink profiles enforcing that at least two of the three datasets contain a crosslink. 338
Crosslink data was visualized using Xvis 25 . Average contact distance was computed by 339 averaging the sequence separation between crosslink pairs in a given dataset. 340 341
Generation of structural models using XL-MS-derived constraints 342
High confidence crosslink pairs identified above were used to generate an ensemble of 343 possible structures using a Rosetta protocol employing the crosslink pairs as structural 344
restraints. The integration of XL-MS derived restraints have been previously used to refine 345 structural models of large complexes 23 and simpler heterodimeric complexes 26 . Based on 346 distance distributions of crosslink pairs mapped onto crystallographic structures we set a 347 lower bound of 15Å and an upper bound of 25Å for lysine Ca pairs in our simulations. 348
Importantly, in our simulations we weighted the constraint pairs as to allow some distances 349 above the upper bound limit. The fragment library was supplanted by using chemical shifts 350 derived from fibrillar tau ssNMR assignments (bmrb entry 17920) using csrosetta 27 obtained in the ion trap for each full spectrum acquired using collision-induced dissociation 387
(CID), with charge 1 ions rejected. Dynamic exclusion was set for 15s after an ion was 388 selected for fragmentation. Raw MS data files were searched against the appropriate protein 389 database from Uniprot, and reversed decoy sequences appended (Elias and Gygi, 2007) by 390
using Protein Discovery 2.2 (Thermo Fisher Scientific). Fragment and precursor tolerances of 391 20ppm and 0.6Da were specified, and 12 missed cleavages were allowed. 392
Carbamidomethylation of Cys was set as a fixed modification and oxidation of Met was set as 393 a variable modification. Label-free quantitation of proteins across samples was performed. 394
Average peptide intensity values were computed for all time points for each peptide. To 395 estimate differences in kinetic profiles we calculated the median value of each profile and 396 compared the Mi to Ms ratio. 397 398 399 RESULTS 400 401
Isolation of fibril-derived monomer and other assemblies 402 We initially sought to define the tau seeding unit that would trigger intracellular aggregation 403 upon direct delivery to the cell interior. We had previously observed that a tau trimer is the 404 minimal assembly size that triggers endocytosis and intracellular seeding 7 . These 405 experiments depended on spontaneous cell uptake, since no Lipofectamine was added to the 406 reactions. A prior study had also indicated the role of disulfide linkages in promoting tau 407 aggregation, potentially by dimer formation 4 . Thus, for our initial studies we engineered and 408 purified full-length (FL) tau monomer that lacks any internal cysteines due to alanine 409 substitutions (C299A and C322A), termed tau (2A). FL tau (2A) cannot self-associate based 410 on disulfide linkages, which helped prevent the formation of cryptic dimers that could have 411 confounded our studies. These substitutions did not affect tau purification, heparin-induced 412 fibrillization, and sonication protocols, which we performed as described previously 7 . We 413 covalently labeled the fibril preps prior to sonication and isolation of recombinant FL tau (2A) 414 assemblies of various sizes by size exclusion chromatography (SEC) 7 . In parallel, we also 415 studied FL wild type (WT) tau. We purified unfibrillized recombinant FL tau (2A) monomer by 416 SEC (Fig. 1A) , and isolated SEC fractions of sonicated fibrils that contained putative 417 monomer, dimer, trimer and ~10-mer ( Fig. 1B) . 418 419
Fibril-derived monomer exhibits seeding activity in cells and in vitro 420
To test the seeding activity of the tau preparations, we used a previously described 421
"biosensor" cell reporter line 9 .These cells stably express 4R tau repeat domain (RD) 422
containing the disease-associated P301S mutation, fused to cyan and yellow fluorescent 423 proteins (RD-CFP/YFP). Exogenously applied seeds induce intracellular aggregation with 424 resultant fluorescence resonance energy transfer (FRET) that can be measured via flow 425 cytometry 9,12 . The degree of aggregation is scored using "integrated FRET density" (IFD), 426
which is the product of the percent positive cells and the mean fluorescence intensity of 427
FRET-positive cells, and from this we determine a titer of tau seeding activity 9 . Lipofectamine 428 directly transduces tau assemblies across the plasma membrane and increases the assay's 429 sensitivity by approximately 100-fold. Upon incubation with Lipofectamine, we were surprised 430 to observe seeding by monomer and larger assemblies alike, whether FL WT or 2A. (Fig.  431 1C,D). Epifluorescence microscopy confirmed the presence of intracellular inclusions after FL 432
WT tau monomer seeding ( Fig. 1D ). We termed the inert monomer "Mi," and the seed-433 competent monomer "Ms." To rule out higher order assemblies of tau within the putative 434 monomer fraction, immediately prior to the seeding assay we passed fractions through a 435 100kDa cutoff filter to eliminate anything larger than a monomer. While monomer fraction 436 retained ~80% of seeding activity, only ~20% of dimer seeding activity remained, and ~1-2% 437 of trimer seeding activity remained ( Fig. 1E ). To exclude an artifact related to Lipofectamine 438
transduction into cells, we tested FL (2A) tau preparations in an in vitro seeding assay that 439 induces fibril formation by full-length tau (0N4R) through iterative polymerization and agitation 440 steps 19 . Mi had no intrinsic seeding activity. However Ms induced amyloid formation, albeit 441 more slowly than trimer or unfractionated fibrils ( Fig. 1F ). This slow aggregation process may 442 reflect inefficient fibril assembly, and a predominance of small nucleated assembly events 443 from the added monomer. We concluded that the Ms fraction contained seeding activity that 444 enabled intracellular aggregation of tau RD-CFP/YFP in cells, or full-length tau in vitro. 445
Finally, we tested whether contamination of very small amounts of seeds could somehow 446 account for the seeding activity in monomer fractions by carrying out dose-response titrations 447 of the various preparations. Ms had an EC50 of ~10nM ( Fig. 1G ), which was very similar to 448 dimer and trimer ( Fig. 1H ). Thus to account for signal observed in the seeding assay, 449
contamination of an otherwise inert monomer with larger seed-competent assemblies would 450 have to be substantial. 451 452
Comparison of Mi and Ms by CD and FCS 453
We tested for obvious structural differences between Mi and Ms using CD spectroscopy, 454
which revealed none ( Fig. 2A ). We re-tested the assemblies using fluorescence correlation 455 spectroscopy (FCS), which measures particle diffusion through a fixed volume. As we 456 previously observed 7 , we accurately estimated the units of small assemblies (≤10-mer), but 457 not larger assemblies (>10-mer) ( Fig. 2B ). In an additional effort to detect cryptic multimers 458 within the Ms preparation, we used double-label FCS. We engineered a cysteine onto the 459 amino terminus of FL tau (2A) to enable its covalent modification (Cys-Tau (2A)). We then 460 prepared Cys-tau (2A) fibrils, or monomer, and labeled them simultaneously with Alexa488 461 (green) and tetramethylrhodamine (TMR) via maleimide chemistry. We carried out sonication 462 and purification by SEC as before, isolating assemblies of various sizes. We evaluated each 463
for cross-correlation between red and green signal, which indicates the presence of at least 464 two tau molecules in a particle. We analyzed >300 events for each assembly. When we 465 evaluated Mi and Ms, 100% of events in each case showed a diffusion time consistent with a 466 tau monomer (Fig. 2C,D) . Furthermore, we observed no cross-correlation between red and 467 green signal, indicating that neither preparation had detectable multimeric assemblies ( Fig.  468 2C,D,H). By contrast, when we evaluated larger species such as dimer, trimer, or ~10-mer, 469
we observed longer diffusion times consistent with the predicted assembly sizes, and 470 significant cross-correlation values ( Fig. 2E-H) , consistent with the presence of multimers. 471
The FCS studies supported the conclusion that Mi and Ms are comprised predominantly of 472 monomer. 473 474 SEC preparation efficiently purifies Ms monomer 475
To rule out cross-contamination of assemblies within the SEC column, we tested its ability to 476 exclude larger seeds from the monomer fraction. We first isolated Ms and larger assemblies 477 from a sonicated fibril preparation ( Fig. 3, Group 1) . Removing the fraction that contained Ms 478 (B5), we then pooled the remaining fractions, and spiked them with Mi. We re-fractionated the 479 material on SEC to isolate the monomer in fraction B5 again ( Fig. 3 , Group 2). As previously 480 observed, Ms and other fibril-derived assemblies in Group 1 had seeding activity ( Fig. 3 ). 481
However, in Group 2, while we observed seeding activity in larger assemblies, the monomer 482
(which we take to be Mi) re-isolated from a pool of larger fibril-derived assemblies had no 483 seeding activity (Fig. 3 ). This confirmed that larger, seed-competent assemblies do not 484 appreciably contaminate the monomer fraction during SEC. 485 486
Heat denaturation of assemblies 487
Although prior controls had essentially excluded the presence of tau multimers in the sample, 488
we used heat-mediated dissociation of oligomeric assemblies as an additional test for the 489 possibility that Ms in fact represents a uniquely compact multimer that somehow purifies as a 490
monomer. We collected Ms by SEC, and heated the sample to 95°C for 3h. We then re-491 isolated the sample via SEC. We carried out the same procedure with trimer and ~20-mer. In 492 each case, we tested the resultant fractions for seeding activity. In the first instance, after 493
heating we re-isolated Ms purely as monomer that retained virtually all of its seeding activity 494 (Fig. 4A ). The trimer assembly (fraction B8) broke down to smaller assemblies, predominantly 495 monomer, each of which retained seeding activity (Fig. 4B ). The ~20-mer (fraction A5) was 496 largely stable following heat treatment, and retained its seeding activity ( Fig. 4C ). These 497 experiments highlighted the lability of small multimers (i.e. trimer), and a surprising 498 persistence of seeding activity in heat-treated monomer. 499 500
Differential heat lability of tau assemblies 501
In the preceding experiment Ms retained seeding activity even after 3h at 95°C, a condition 502 sufficient to dissociate trimers. These experiments implied that Ms consists of a stable seed-503 competent structure, resistant to heat denaturation. Consequently, we used more nuanced 504
heat denaturation of seeding activity to probe the relative stabilities of Ms, dimer, trimer, and 505 larger assemblies of FL WT tau. We first isolated tau monomer, dimer, trimer, ~10-mer, and 506 ~20-mer on SEC. We then incubated the various assemblies at a range of temperatures (65,  507 75, 85, 95°C) and times (0, 3, 12, 18, 24, 48, 72h) before measuring seeding activity. Lower 508 temperatures only slightly reduced seeding activity, whereas exposure of Ms, dimer, and 509 trimer to temperatures ≥85°C for 18-24h eliminated it at roughly the same rate for each ( Fig.  510 4D-G). By contrast, the seeding activities of ~10-mer and ~20-mer were relatively heat-511 resistant ( Fig. 4D -G). This was consistent with our prior observations that tau seeds derived 512 from cultured cells are resistant to boiling 11 . To determine a putative energy barrier between 513
Ms and Mi, we evaluated the denaturation data for Ms by integrating the data from the prior 514 experiments ( Fig. 4H ). We compared two models for the transition of Ms to an inert form 515
(which we assumed to be an unfolding reaction): a unimodal unfolding model vs. a 516 multimodal model that assumes intermediate seed-competent states. The unimodal model 517 did not account for the data at early time points, which indicated a lag phase in denaturation, 518 whereas the multimodel model performed better (Fig. 4H ). The lag phase in denaturation 519
implied an ensemble of seed-competent states that define Ms, each separated by smaller 520 energy barriers. Using the multimodal model, we calculated the barrier to conversion of Ms to 521 an inert form to be ~78 kcal/mol. 522 523
Ms has unique properties of self-assembly 524
Aggregation of Mi in vitro is relatively slow, requires high protein concentration (micromolar), 525 and polyanions such as heparin 13, 14 . Based on the seeding activity of Ms we predicted that it 526 might more readily self-associate. We incubated FL WT tau Mi and Ms alone, or dimer or 527 trimer at equimolar ratios, keeping total particle concentration constant at 500nM. We then 528 monitored change in assembly size over 24h. Mi, dimer, and trimer showed no evidence of 529 self-association in this timeframe ( Fig. 5A ,C,D). By contrast, when incubated alone, Ms 530 readily formed larger assemblies ( Fig. 5B ). When we incubated Mi with dimer or trimer, we 531 saw no change in the assembly population over 24h ( Fig. 5E,F) . By contrast, when we mixed 532
Ms with dimer or trimer we observed a growth of larger assemblies with a concomitant 533 reduction in dimer and trimer peaks ( Fig. 5G,H) . We conclude that Mi, dimer, and trimer do 534 not form larger assemblies at an appreciable rate, while Ms self-assembles and adds on to 535 larger assemblies. 536 537
Heparin induces transition from Mi to Ms 538
The preparation of Ms based on sonication of fibrils raised two important issues. First, it left 539 uncertain whether Mi could be converted to a seed-competent form without previously being 540 incorporated into a fibril. Second, we observed that sonication could create fragments from 541 tau monomer that might potentially act as seeds (Supp. Fig. S6A ). Consequently, we used 542 heparin to induce the formation of Ms, thereby avoiding sonication. We exposed FL WT tau to 543 heparin for varying amounts of time before purifying different assembly sizes by SEC and 544 testing for seeding activity. After 15min of heparin exposure, we detected low but significant 545 amounts of seed-competent monomer, and much fewer larger assemblies (Fig. 6A ). 546
Crosslinking of purified, heparin-induced Ms revealed no evidence of multimers or an 547 increase in fragments (Supp. Fig. S6B ). Recombinant monomer not treated with heparin had 548 no seeding activity at any time point ( Fig. 6A) . At longer heparin treatment times (1h, 4h) 549 monomer fractions as well as larger assemblies all had strong seeding activity (Fig. 6A ). Ms 550 derived from heparin exposure was relatively resistant to heat denaturation at 95°C, albeit 551 less so than fibril-derived Ms (Fig. 6B ). Relative seeding efficiency of the various forms of Ms 552 as well as sonicated or unsonicated fibrils were relatively similar ( Fig. 6C ). We noted also that 553 sonication of Mi and purification by SEC did not produce any seed-competent species, 554 eliminating the possibility that small assemblies of sonication-induced fragments accounted 555
for seeding activity of Ms (Fig. 6C) . These experiments also indicated that it is not necessary 556
for tau monomer to be part of a fibril or to be exposed to sonication to produce an efficient 557 seed-competent monomer. Heparin, presumably by catalyzing a transition from an inert to a 558 seed-competent form, enables this critical conformational change. 559 560
XL-MS reveals unique contacts associated with Ms 561
To probe the structures of Mi and Ms, we employed cross-linking with mass spectrometry (XL-562 MS), which uses DSS-mediated crosslinking of proteins (monomer or larger assembly) 563 followed by trypsin proteolysis, enrichment of resultant fragments by SEC, and identification 564 by capillary liquid chromatography tandem mass spectrometry (MS). This method creates 565 restraints for structural models of single proteins or protein complexes 23,28,29 . We assigned 566 the complex fragment ion spectra to the corresponding peptide sequences using xQuest 24 . 567
Denaturation of recombinant tau with 8M urea prior to crosslinking produced no 568 intramolecular cross-links (data not shown), indicating that crosslinks observed under native 569 conditions represented local structure. We studied Mi, fibril-derived Ms and heparin-derived 570
Ms using XLMS. Short reaction times ensured the production of only intra-molecular 571 crosslinks as monitored by SDS-PAGE (Fig. S6) . XL-MS for each sample was carried out in 572 triplicate (Suppl . Table S1 ), and only considering consensus crosslinks present in each 573 replicate (Suppl . Table S2 ). Mi exhibited crosslink patterns which indicated local and distant 574 intramolecular contacts (Fig. 7A ). In Ms, we observed a consistent crosslinking of K150 with 575 K254, K267, K274 or K280 all located between RD 1 and 2. These crosslinks tracked 576 exclusively with Ms, both fibril-or heparin-derived ( Fig. 7B,C) . We never observed these 577 crosslinks in Mi. To test the relationship of this crosslink with seed function, we carried out 578 heat denaturation at 95°C for 3 or 24h, followed by XL-MS. Heating samples results in a 579 decrease in crosslink frequency (Fig. S7) . Importantly, however, we observed a parallel 580 persistence of this crosslink pattern with seeding activity (Fig. 7B,C) . The XL-MS results 581 indicate a distinct structure and seeding activity for Ms that is surprisingly resistant to 582 denaturation at 95°C. 583 584 AD brain contains Ms 585
Given our experiments with recombinant Mi and Ms, we wished to test whether similar 586 structures exist in vivo. We extracted AD and control brain samples using a dounce 587 homogenizer to avoid liberating significant monomer from fibrils. We immunoprecipitated tau 588
using an antibody that targets the amino-terminus (HJ8.5), and resolved the eluates by SEC, 589
followed by ELISA to determine tau levels (Fig. 8A,B) . Tau from control brain purified in the 590 monomer fraction (Fig. 8A) , while tau from AD brain distributed across multiple fractions, 591
corresponding to monomer and larger assemblies (Fig. 8B ). When we tested each fraction for 592 seeding activity, we observed none in any control brain fraction (Fig. 8C ). However, all AD 593 fractions contained seeding activity, including monomer ( Fig. 8C ). To exclude the possibility 594 that the brain homogenization protocol liberated Ms from neurofibrillary tangles, we spiked tau 595
KO mouse brain samples with recombinant fibrils in vitro, or fibril-derived Ms. We then used 596 dounce homogenization and immuno-purification as for human brain. We evaluated the 597 seeding activity in total lysate, supernatant following 10,000 x g centrifugation, and SEC 598 fractions ( Fig. 8D ). We readily observed monomer seeding activity in tau KO brain spiked 599
with Ms, however we observed none in fractions that had been spiked with fibrils ( Fig. 8D ). 600
The homogenization protocol for human brain was thus unlikely to have liberated Ms from 601 pre-existing tau fibrils. 602 603
To test for self-association of control-derived Mi vs. AD-derived Ms, we purified these species 604
by SEC, and divided each monomer fraction in two. We snap-froze one fraction and 605 incubated the other overnight at room temperature. Then we again resolved the assemblies 606 via SEC and tested each fraction for seeding activity. Control monomer was inert, even after 607 incubation at RT (Fig. 8E ). AD-derived Ms that was purified, frozen, and re-purified by SEC 608 exhibited seeding activity exclusively in the monomer fraction ( Fig. 8E ). By contrast, AD-609
derived Ms incubated at RT formed seed-competent assemblies of increasing size (Fig. 8E) . 610 We concluded that, as for other types of Ms, AD-derived Ms exhibited an intrinsic capacity for 611 self-association into seed-competent assemblies. To compare structures of control vs. AD-612 derived monomer via XL-MS, we isolated tau from brains of 3 AD patients and 3 age-613 matched controls. In control-derived monomer, we observed no evidence of the crosslink that 614 marked Ms (Fig. 8G ). However, in each AD-derived Ms sample we observed a discrete set of 615 crosslinks between aa150 and aa259-290 ( Fig. 8H ). This essential finding did not change, no 616 matter what method of homogenization we used (Supp. Fig. S8 , Suppl. Table S3 ), and 617
implied a common structure that unifies ensembles of seed-competent tau monomer, whether 618 produced in vitro or in vivo. 619 620
Models of seed-competent monomer suggest exposure of VQIINK and VQIVYK 621
Based on intramolecular FRET and electron paramagnetic resonance spin labeling 622
Mandelkow et al. have previously proposed native tau structure to be in a "paperclip" 623 configuration, with the C-terminus folded over the RD 30 . To understand how core elements of 624 tau control its aggregation, we employed Rosetta to create models of tau structure for Mi and 625 Ms using restraints from the crosslink patterns and length of the DSS crosslinker. The overall 626 energetics and radii of gyration in the models were comparable for Mi and Ms (Fig. S9 ), 627
indicating global structural similarity. We thus focused on the RD, given its high frequency of 628 intramolecular crosslinks, and primary role in aggregation (Fig. 9A ). We observed differences 629 in the predicted interface structure between R1/R2 and R2/R3 which encode two core 630 VQIINK and VQIVYK motifs critical for tau amyloid formation 31, 32 . The Mi structural model 631 predicted masking of VQIINK and VQIVYK sequences in compact "hairpin" structures ( Fig.  632 9B, Supp. Movie Mi), similar to the structure of microtubule-bound tau previously determined 633 by NMR 33 . By contrast, within Ms the model predicted relative exposure of VQIINK and 634 VQIVYK (Fig. 9C , Supp. Movie Ms). We next evaluated XL-MS-guided predictions of patient-635 derived tau, although lower sample quality and fewer high confidence crosslinks (possibly 636 due to protein heterogeneity) limited our accuracy. As for recombinant protein, Mi from control 637 patients also featured VQIINK/VQIVYK sequences in a less accessible configuration (Fig. 9D,  638 Supp. Table S1 ; Supp. Movie: Control1). In AD-derived Ms, long-range contacts from aa150 639
to R2 influenced the model, and predicted an exposed configuration of VQIINK/VQIVYK ( Fig.  640 9E, Limited proteolysis supports models of exposed VQIINK/VQIVYK sequences 645
As an orthogonal comparison of the structures of Mi and Ms, we used limited proteolysis with 646 trypsin. Mi or Ms (heparin-exposed) that had been passed through a 100kD filter immediately 647
prior were subjected to a fine time course of limited proteolysis (Fig. 10A ). Each sample was 648 prepared in triplicate with matched protein quantities to facilitate label-free analysis. We then 649 used mass spectrometry to evaluate the production of tau fragments and mapped these to 650 specific cleavage sites. We identified 60 peptides common across the two conditions (Suppl. 651 Table S4 ). To summarize enrichment of peptides across the two datasets we compared the 652 ratio of averaged kinetic profiles (Fig. S10) . Differences between the Mi and Ms primarily 653 localized to the RD (Fig. S10 ). In Mi, an R1R2 fragment was enriched ( Fig. 10C) while only 654 the R2 portion of that fragment was enriched in Ms (Fig. 10D ). We observed similar patterns 655 in R2R3 (Fig. 10F,G) . By contrast, other domains outside of these regions had similar 656 cleavage kinetics in Mi and Ms (Fig. 10E,H, Fig. S10 ). Mapping these cleavage sites onto our 657 structural models revealed that proteolysis in Mi preferentially occurred outside the hairpin 658 that includes VQIINK and VQIVYK amyloid sequences, while cleavage in Ms occurred 659 adjacent to the amyloid sequences ( Fig. 10I,J) . The cleavage patterns were thus consistent 660 with structural models of VQIINK and VQIVYK regions, which predicted relative inaccessibility 661 of hairpin-associated sequences in Mi, and accessibility in Ms. 662 663 664
Discussion 665 666
We propose that tau monomer occupies two distinct and stable conformational ensembles. 667
One set of structures (collectively termed Mi) is relatively inert, while another has intrinsic 668 ability to self-assemble, and acts as a template, or seed, for fibril growth in vitro and in cells 669
(collectively termed Ms). Multiple controls indicated that our original preparation of fibril-670 derived Ms is in fact a monomer, uncontaminated by larger assemblies. Tau monomer 671 purified from AD brain also had intrinsic seeding activity, and self-associated to produce 672 larger seed-competent assemblies. A model restrained by the XL-MS data, and consistent 673 with biochemical studies, predicts that VQIVYK and VQIINK sequences assume an open 674 configuration in all types of Ms (fibril-derived, heparin-induced, and AD-derived). By contrast, 675 the model predicts lack of VQIINK/VQIVYK exposure in Mi. Limited proteolysis studies are 676 consistent with this idea, although clearly more detailed biochemical, biophysical, and 677 structural analyses will be needed to test its validity. Taken together, these data establish a 678 new concept for tau: this intrinsically disordered protein has multiple, stable monomeric 679 states, functionally distinguished by the presence or absence of seeding activity. 680 681
Amyloid proteins form progressively larger assemblies over time, and it has been difficult to 682 define the composition of the minimal seed. Mandelkow and colleagues studied tau 683 aggregation in vitro and concluded that a seed of 8-12 molecules existed in their 684 experimental system 4 . By contrast, Kuret and colleagues posited an "intermediate" of tau that 685 could subsequently initiate self-assembly, and their data, based on extrapolation of tau 686 concentrations needed to enable development of thioflavin fluorescence in vitro, were 687 consistent with a monomeric seed 1 . Wetzel and colleagues also proposed that a monomer is 688 the basis of a "thermodynamic nucleus" that templates the aggregation of synthetic 689 polyglutamine peptides 34 . However, no prior study has previously identified stable forms of 690 tau monomer that seed amyloid formation. 691 692
The actual cause of tau aggregation in tauopathies is unknown. It has been proposed that 693 dissociation of tau monomer from microtubules, possibly due to phosphorylation, allows high 694 concentration and self-association to form pathogenic assemblies 35 . In this study, using a 695 single source of recombinant protein, we define distinctly structured seed-competent and 696 inert forms of tau. We have similarly identified seed-competent species in human brain. In 697 reality "seed-competent" and "inert" forms of tau almost certainly represent multiple structural 698 ensembles separated by defined energy and/or kinetic barriers. The barrier for conversion of 699 an inert to a seed-competent form of tau can apparently be overcome by incubation with 700 heparin and/or incorporation into a fibril. In neurons, other factors such as post-translational 701 modifications and heterologous binding events likely play a role. Identification of the factors 702 that trigger conversion from inert to seed-competent forms will thus have obvious implications 703 for understanding disease mechanisms. 704 705
Isolation of seed-competent monomer from AD brain, with a very mild purification that 706 explicitly excludes sonication or vigorous tissue homogenization, strongly suggests that this 707 form of tau exists in vivo. Furthermore, we observed that both recombinant Ms and AD-708
derived Ms build multimeric assemblies in vitro far more efficiently than Mi or control-derived 709 monomer. Thus, we hypothesize that a uniquely structured form of tau may be required for 710 efficient assembly growth in cells. This contrasts with the idea that multimeric assemblies 711 uniquely stabilize the conformation of otherwise unstructured proteins as they incorporate into 712 the growing fibril, or that liquid-liquid phase separation with extremely high local concentration 713 underlies tau aggregation 36 . Instead, we imagine that the initiation of aggregation in human 714 brain might begin with a stable transition of tau monomer from an inert to a seed-competent 715 form. To fully study this process will require more extensive biochemical purification of tau Ms 716 from the earliest stages of disease. 717 718
Ms has a remarkably stable structure, as it resists heat denaturation at 95°C for up to 3h. This 719 suggests a heretofore unrecognized conformation of tau that, to account for its slow 720 denaturation, likely involves multiple intra-molecular interactions involving short and long 721 range amino acid contacts. XL-MS provides some indication of what these might be, and 722 crosslinks between aa150 and R2 appear to mark a seed-competent conformation. In 723 agreement with the XL-MS results, we observed that heat inactivation of Ms seeding activity 724 occurs with a lag phase, rather than first order time-dependent decay. This implies a complex 725 tertiary structure in which Ms has multiple seed-competent intermediates. Future XL-MS 726 studies performed at different temperatures could reveal these structures. With more 727 advanced methods to interrogate the structure of monomeric tau in patient material, we 728
imagine that "seed-competent monomer" will in fact represent myriad structures, depending 729 on the underlying disease. This could provide an explanation for how a single tau protein 730 might self-assemble into diverse amyloid strains. We note with excitement a recent study of 731 the yeast prion Sup35 from the Tanaka laboratory. Like tau, Sup35 is intrinsically disordered, 732 yet they have observed local structure that influences the conformations of fibrils it can 733 form 37 . 734 735
Without further studies to identify structures of tau at higher resolution, we cannot know for 736 certain why one form acts as a seed and another does not. However, we gained important 737 insights when we modeled the configurations of R1R2 and R2R3 using Rosetta, with 738 crosslinks as restraints. With obvious caveats, our models predicted that the local 739 environment surrounding two hexapeptide motifs, VQIINK and VQIVYK, which are required 740 for tau to form amyloid structures, may explain the differences between seed-competent and 741 inert forms. In the models of Mi, and control brain-derived tau, these motifs lie buried in 742 hairpin structures. By contrast, in Ms and AD-derived tau, both are exposed. VQIINK and 743
VQIVYK thus might mediate intermolecular interaction in a growing assembly. In support of 744 our structural model, the proteolysis experiments corroborate differences in exposure of the 745 VQIINK and VQIVYK sequences in the R1R2 and R2R3 regions between Mi and Ms. We note 746
with great enthusiasm the recent study of Fitzpatrick et al. 38 , which defined critical 747 sequences of tau within the amyloid core that are based on VQIVYK and adjacent amino 748 acids. Indeed, it has been recently observed that heparin binding involves residues spanning 749 270-290, and promotes expansion of the remainder of the molecule 39 . This is consistent with 750 our predictions of relative exposure of VQIINK/VQIVYK. The diversity of exposed core 751 elements (almost certainly beyond VQIINK/VQIVYK) could specify the formation of 752 assemblies that give rise to distinct strains, as suggested by work from the Tanaka 753 laboratory 37 . Consistent with this idea, the Fitzpatrick et al. study indicates that in AD-derived 754 tau fibrils the VQIVYK sequence plays a key role in the core amyloid structure (along with 755 adjacent amino acids), but the VQIINK sequence does not 38 . We also note that multiple 756 disease-associated mutations in tau affect residues in close proximity to VQIINK/VQIVYK. 757
For example, our models predict that serine or leucine substitutions at P301 (which cause 758 dominantly inherited tauopathy) would uniquely destabilize the local structure and promote 759 exposure of the VQIINK/VQIVYK sequences. Future experiments will test these ideas more 760
definitively. 761 762
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